共查询到20条相似文献,搜索用时 31 毫秒
1.
《Current medical research and opinion》2013,29(6):1097-1107
Abstract
Objective:
To examine the impact of baseline severity on lisdexamfetamine dimesylate (LDX) efficacy in a long-term study of adults with attention-deficit/hyperactivity disorder (ADHD). 相似文献2.
《Current medical research and opinion》2013,29(7):1089-1099
Abstract
Objectives:
The CHOICE study was a prospective, multicentre, observational study designed to assess levels of adherence in current clinical practice to the European product label and EORTC guidelines for the treatment of chemotherapy-induced anaemia (CIA) with darbepoetin alfa (DA). Here we present data split by tumour types: breast, colorectal, ovarian and lung. 相似文献3.
《Current medical research and opinion》2013,29(11):2627-2628
Abstract
Objective:
To determine the safety and efficacy of full-length parathyroid hormone, PTH(1–84), treatment for up to 36 months by evaluating bone mineral density (BMD) changes, bone histomorphometric indices, and clinical fracture incidence in postmenopausal women with osteoporosis. 相似文献4.
《Current medical research and opinion》2013,29(4):581-589
Abstract
Objective:
Bariatric surgery is an effective treatment for the reduction of weight in obese patients (BMI?≥?40?kg/m2 or 30?kg/m2 with ≥1 comorbidities), who are refractory to behavioral and medical therapies. This study examined the effect of the adjustable gastric band (AGB) system on changes in gastroesophageal reflux disease (GERD) and patient-reported outcomes, including measures of quality of life. 相似文献5.
《Current medical research and opinion》2013,29(10):2549-2555
Abstract
Objective:
To identify predictors of improved asthma control under conditions of everyday practice in Switzerland. 相似文献6.
《Current medical research and opinion》2013,29(9):1763-1768
Abstract
Background:
The prevalence of pulmonary arterial hypertension (PAH) and chronic thromboembolic pulmonary hypertension (CTEPH) in the US is largely unknown. Prior research has estimated PAH prevalence in Europe at ~15–52 per million. 相似文献7.
《Current medical research and opinion》2013,29(10):2411-2419
Abstract
Objective:
Postherpetic neuralgia and painful diabetic peripheral neuropathy are common chronic neuropathic pain conditions associated with sleep disturbances. Pregabalin is indicated in the treatment of neuropathic pain. The objective of this review is to summarize the efficacy and safety of pregabalin in painful diabetic peripheral neuropathy and postherpetic neuralgia and the effect of pregabalin on sleep interference in these patients. 相似文献8.
《Current medical research and opinion》2013,29(8):957-966
Abstract
Objective:
Since many patients with COPD in the US are managed by primary care physicians, we evaluated adherence to the Global Initiative for Chronic Obstructive Lung Disease (GOLD) guidelines in a primary care setting. 相似文献9.
《Current medical research and opinion》2013,29(6):1243-1253
Abstract
Objective:
To demonstrate that a fixed-dose combination of enteric-coated naproxen 500?mg and immediate-release esomeprazole magnesium 20?mg has comparable efficacy to celecoxib for knee osteoarthritis. 相似文献10.
《Current medical research and opinion》2013,29(9):1093-1104
Abstract
Background:
Attention-deficit/hyperactivity disorder (ADHD) is a chronic neurobiological disorder with childhood onset and persistence into adolescence and adulthood. 相似文献11.
《Current medical research and opinion》2013,29(12):2835-2843
Abstract
Objective:
Multi-attribute decision-making (MADM) models evaluate competing solutions for complex problems to identify the closest fit to the ideal solution. MADM models may assist dermatologists when selecting between biologics for plaque psoriasis. Here, is described the development of a pilot model to identify the preferred biologic from the dermatologist's perspective. 相似文献12.
《Current medical research and opinion》2013,29(9):1435-1445
Abstract
Objective:
To evaluate if there is a correlation between some new emerging biomarkers, such as lipoprotein(a) (Lp[a]), apo(a) isoform phenotyping, soluble advanced glycation end products (sRAGE), soluble CD40 ligand (sCD40L), serum myeloperoxidase (MPO), and cardiovascular risk stratification. 相似文献13.
《Current medical research and opinion》2013,29(3):251-258
Abstract
Objective:
Larch arabinogalactan (ResistAid) may prevent cold infections due to its immune-stimulatory properties. In a placebo-controlled, double-blind, randomized clinical trial, the effect of a proprietary larch arabinogalactan preparation on the incidences of common colds and its effect on cold symptoms, as a well established model for immune function, was compared to placebo. 相似文献14.
《Current medical research and opinion》2013,29(5):781-788
Abstract
Objective:
To evaluate the intraocular pressure (IOP)-lowering efficacy and safety of fixed-combination brimonidine 0.2%–timolol 0.5% compared with latanoprost 0.005% in patients with glaucoma or ocular hypertension. 相似文献15.
《Current medical research and opinion》2013,29(3):303-313
Abstract
Objective:
To better understand depression’s impact on family functioning from the perspectives of patients with major depressive disorder (MDD) and their partners; to develop and test patient and partner versions of a new self-reported measure, the Depression and Family Functioning Scale (DFFS), for use in clinical trials. 相似文献16.
《Current medical research and opinion》2013,29(5):987-994
Abstract
Objective:
To evaluate adherence to European Organisation for Research and Treatment of Cancer (EORTC) and European Summary of Product Characteristic (SmPC) guidance on recommended haemoglobin (Hb) values in routine clinical practice use of darbepoetin alfa (DA) in cancer patients internationally. 相似文献17.
《Current medical research and opinion》2013,29(12):2745-2755
Abstract
Objective:
Menorrhagia, or heavy menstrual bleeding (HMB), has a negative impact on women’s quality of life (QOL). The objective was to develop, validate, and assess the performance of a disease-specific patient-reported outcome (PRO) measurement instrument for HMB (the Menorrhagia Impact Questionnaire [MIQ]). 相似文献18.
《Current medical research and opinion》2013,29(7):827-833
Abstract
Objective:
We examined whether identification of patients with placebo-remitter characteristics and placebo-nonremitter characteristics enhances the ability to identify drug–placebo treatment differences and, perhaps, differences between agents in major depressive disorder (MDD). We hypothesized: 1) that drug–placebo differences in remission rates would be greater for both duloxetine and selective serotonin reuptake inhibitors (SSRIs) among placebo nonremitters than placebo remitters and: 2) that the difference between active treatments would also be greater in placebo nonremitters than placebo remitters. 相似文献19.
《Current medical research and opinion》2013,29(3):579-588
Abstract
Background:
Since the recognition of alpha-1 antitrypsin deficiency (A1ATD) in 1963, interest in this condition has increased dramatically. A1ATD is now recognized as the only known genetic condition that leads to emphysema/chronic obstructive pulmonary disease (COPD) in many individuals with the condition. Augmentation therapy with plasma-derived alpha-1 antitrypsin (A1AT) was first introduced in 1987. 相似文献20.
Measurement of utility values in the UK for health states related to immune thrombocytopenic purpura
《Current medical research and opinion》2013,29(8):1893-1903
Abstract